237 related articles for article (PubMed ID: 19291800)
21. Assessment of chromosomal trisomies in prostate cancer using fluorescent in situ hybridization.
Mark HF; Feldman D; Das S; Samy M; Sun CL; Mark S
Exp Mol Pathol; 1999 Oct; 67(2):109-17. PubMed ID: 10527762
[TBL] [Abstract][Full Text] [Related]
22. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
[TBL] [Abstract][Full Text] [Related]
23. Enumeration, characterization, and collection of intact circulating tumor cells by cross contamination-free flow cytometry.
Takao M; Takeda K
Cytometry A; 2011 Feb; 79(2):107-17. PubMed ID: 21246706
[TBL] [Abstract][Full Text] [Related]
24. Automatic detection and genetic profiling of disseminated neuroblastoma cells.
Méhes G; Luegmayr A; Hattinger CM; Lörch T; Ambros IM; Gadner H; Ambros PF
Med Pediatr Oncol; 2001 Jan; 36(1):205-9. PubMed ID: 11464886
[TBL] [Abstract][Full Text] [Related]
25. A "live" biopsy in a small-cell lung cancer patient by detection of circulating tumor cells.
Bevilacqua S; Gallo M; Franco R; Rossi A; De Luca A; Rocco G; Botti G; Gridelli C; Normanno N
Lung Cancer; 2009 Jul; 65(1):123-5. PubMed ID: 19261349
[TBL] [Abstract][Full Text] [Related]
26. Using circulating tumor cells as a prognostic indicator in metastatic castration-resistant prostate cancer.
Delacruz A
Clin J Oncol Nurs; 2012 Apr; 16(2):E44-7. PubMed ID: 22459536
[TBL] [Abstract][Full Text] [Related]
27. Circulating tumor cells in pulmonary venous blood of primary lung cancer patients.
Okumura Y; Tanaka F; Yoneda K; Hashimoto M; Takuwa T; Kondo N; Hasegawa S
Ann Thorac Surg; 2009 Jun; 87(6):1669-75. PubMed ID: 19463575
[TBL] [Abstract][Full Text] [Related]
28. Circulating tumor cells in metastatic breast cancer: timing of blood extraction for analysis.
Martín M; García-Sáenz JA; Maestro De las Casas ML; Vidaurreta M; Puente J; Veganzones S; Rodríguez-Lajusticia L; De la Orden V; Oliva B; De la Torre JC; López-Tarruella S; Casado A; Sastre J; Díaz-Rubio E
Anticancer Res; 2009 Oct; 29(10):4185-7. PubMed ID: 19846970
[TBL] [Abstract][Full Text] [Related]
29. User-defined protein marker assay development for characterization of circulating tumor cells using the CellSearch® system.
Lowes LE; Hedley BD; Keeney M; Allan AL
Cytometry A; 2012 Nov; 81(11):983-95. PubMed ID: 22899576
[TBL] [Abstract][Full Text] [Related]
30. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells.
Zheng S; Lin H; Liu JQ; Balic M; Datar R; Cote RJ; Tai YC
J Chromatogr A; 2007 Aug; 1162(2):154-61. PubMed ID: 17561026
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
32. Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer.
Okegawa T; Hayashi K; Hara H; Nutahara K; Higashihara E
Int J Urol; 2010 Mar; 17(3):254-8. PubMed ID: 20148989
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of metastasis of circulating human prostate cancer cells in the chick embryo by an extracellular matrix produced by foreskin fibroblasts in culture.
Menen R; Pinney E; Hassanein MK; Kolostova K; Bobek V; Suetsugu A; Zhang N; Bouvet M; Naughton GK; Hoffman RM
Anticancer Res; 2012 May; 32(5):1573-7. PubMed ID: 22593434
[TBL] [Abstract][Full Text] [Related]
34. Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result.
Kurihara T; Itoi T; Sofuni A; Itokawa F; Tsuchiya T; Tsuji S; Ishii K; Ikeuchi N; Tsuchida A; Kasuya K; Kawai T; Sakai Y; Moriyasu F
J Hepatobiliary Pancreat Surg; 2008; 15(2):189-95. PubMed ID: 18392713
[TBL] [Abstract][Full Text] [Related]
35. Fluorescence in situ hybridization analysis of human oocytes: advantages of a double-labeling procedure.
Pellestor F; Anahory T; Andréo B; Régnier-Vigouroux G; Soulié JP; Baudouin M; Demaille J
Fertil Steril; 2004 Oct; 82(4):919-22. PubMed ID: 15482769
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
[TBL] [Abstract][Full Text] [Related]
37. Let me do more than count the ways: what circulating tumor cells can tell us about the biology of cancer.
Budd GT
Mol Pharm; 2009; 6(5):1307-10. PubMed ID: 19634916
[TBL] [Abstract][Full Text] [Related]
38. External quality assurance of circulating tumor cell enumeration using the CellSearch(®) system: a feasibility study.
Kraan J; Sleijfer S; Strijbos MH; Ignatiadis M; Peeters D; Pierga JY; Farace F; Riethdorf S; Fehm T; Zorzino L; Tibbe AG; Maestro M; Gisbert-Criado R; Denton G; de Bono JS; Dive C; Foekens JA; Gratama JW
Cytometry B Clin Cytom; 2011 Mar; 80(2):112-8. PubMed ID: 21337491
[TBL] [Abstract][Full Text] [Related]
39. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
[TBL] [Abstract][Full Text] [Related]
40. Circulating tumor cells: detection, molecular profiling and future prospects.
Jacob K; Sollier C; Jabado N
Expert Rev Proteomics; 2007 Dec; 4(6):741-56. PubMed ID: 18067413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
